title: Editorial Comment to High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy.
authors.affiliation: Department of Urology, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands. r.vansoest@erasmusmc.nl.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: van Soest
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008214:Lymphocytes; D008297:Male; D009504:Neutrophils; D064129:Prostatic Neoplasms, Castration-Resistant / Q000097:blood* / Q000188:drug therapy*; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D043823:Taxoids